IL17A and acute respiratory distress syndrome: It has further been reported, in an experimental model, that viral persistence, by producing a persistent augmentation of IL-17, provokes ARDS (acute distress respiratory syndrome) [43], just as it occurs in SARS-CoV-2 infection.